RESMED INC

RMD

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0000943819-26-000014
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: FARRELL PETER C (Director)
SEC Filing link

Summary

Type

Sell

Net shares

-2,000

% of shares

-3.09%

Amount (USD)

$520,440

Insider confidence score

37.5 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Significant scheduled sell (<5% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

ResMed Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-2,000.0

Price per Share

$260.22

Amount (USD)

$520,440.00

Acquired/Disposed

Disposed

Shares Owned Before

64,773.0

Shares Owned After

62,773.0

Filing's footnotes

1. The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.